Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-Month interim results of a randomized, evaluator-blinded, intra-individual comparison study

Journal of Cosmetic and Laser Therapy

Volumn 13, Issue 3, 2011, Pages 107-112

  Rzany, Berthold ^a   Bayerl, Christiane ^b   Bodokh, Isaac ^c   Boineau, Dominique ^d   Dirschka, Thomas ^e   Queille Roussel, Catherine ^f   Sebastian, Michael ^g   Sommer, Boris ^h   Poncet, Michel ⁱ   Guennoun, Mohammed ⁱ   Podda, Maurizio ^j  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Cannes Hospital   (France)

^d Centre Dermato chirurgical et Médecine de la Nutrition   (France)

^e Dermatologische Praxis   (Germany)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^g FÄ für Dermatologie ^*  (Germany)

^h Dr Boris Sommer   (Germany)

ⁱ Galderma R and D   (France)

^j KLINIKUM DARMSTADT   (Germany)

more..

Author keywords

efficacy; filler; hyaluronic acid; safety

Indexed keywords

EMERVEL; HYALURONIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMATOMA; HUMAN; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE NODULE; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; WRINKLE SEVERITY RATING SCORE;

ADULT; COSMETIC TECHNIQUES; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; SKIN AGING;

EID: 79957796323     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764172.2011.571699     Document Type: Article

References (16)

1. Andre P. Hyaluronic acid and its use as a 'rejuvenation' agent in cosmetic dermatology. Semin Cutan Med Surg. 2004; 23:218-222. (Pubitemid 43180995)
2. Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: Scientific and technical considerations. Plast Reconstr Surg. 2007;120(suppl):33S.
3. Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143:155-163. (Pubitemid 46294581)
4. Richter AW, Ryde EM, Zetterstrom EO. Nonimmunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Allergy Appl Immunol. 1979;59:45-48. (Pubitemid 9186658)
5. Larsen NE, Pollak CT, Reiner K, Leshchiner E, Balazs EA. Hylan gel biomaterial: Dermal and immunologic compatibility. J Biomed Mater Rev. 1993;27:1129-1134. (Pubitemid 23241076)
6. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28: 491-494. (Pubitemid 34686633)
7. Hamilton RG, Strobos J, Adkinson NF Jr. Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic acid particles. Dermatol Surg. 2007;33(S2): S176-S185. (Pubitemid 350233457)
8. Dover JS, Carruthers A, Carruthers J, Alam M. Clinical use of Restylane. Skin Therapy Lett. 2005;10:5-7.
9. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003; 29:588-595. (Pubitemid 36702442)
10. Rao J, Chi GC, Goldman MP. Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: Hylaform versus Restylane. Dermatol Surg. 2005; 31:1587-1590.
11. Beer K. A randomized, evaluator-blinded comparison of efficacy of hyaluronic acid gel and avian-sourced Hylan B Plus gel for correction of nasolabial folds. Dermatol Surg. 2007;33:928-936. (Pubitemid 47106733)
12. Narins RS, Dayan SH, Brandt FS, Baldwin EK. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg. 2008;34:S2-S8. (Pubitemid 351792840)
13. Narins RS, Brandt FS, Lorence ZP, Maas CS, Monheit GD, Smith SR, et al. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and nonanimal-stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg. 2007;33(S2):S213-S221. (Pubitemid 350233466)
14. Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: A multicenter, double-masked, randomized, withinsubject study. Dermatol Surg. 2007;33:S128-S135. (Pubitemid 350233450)
15. Matarasso SL, Carruthers JD, Jewell ML and the Restylane Consensus Group. Consensus recommendations for softtissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg. 2006;117(3 suppl): 3S - 34S. (Pubitemid 44321386)
16. Glogau RG, Kan MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid dermal fillers. Dermatol Surg. 2008; 34:S105-S109. (Pubitemid 351792859)